Asthma Biologics: Who They Are For and How You Qualify

There's a version of asthma that doesn't show up in the pamphlets.

You take the controller inhaler every morning. You've had your technique checked, and you don't skip doses. You still carry the rescue inhaler everywhere, because you've learned the hard way what happens when you don't. Sometime in the last year you've been on prednisone more than once, and you remember the second course better than the first, because of what it did to your sleep and your mood.

You've also started making quiet arrangements around your lungs. You pick the aisle seat near the door. You skip the friend's house with the cat. You've stopped saying yes to hikes in September. Nobody around you would call you sick, exactly, but you've reorganized your life to keep the coughing down.

If that's your experience, you're in the group this article is for. Not asthma that's a nuisance. Asthma that's still winning after you've done everything right.

What a biologic actually is

A biologic is a lab-made antibody that blocks one specific signal inside your immune system.

Your immune system communicates with itself using small messenger proteins. In allergic and inflammatory asthma, a handful of those messengers keep telling your airways to swell, produce mucus, and tighten. A biologic is engineered to grab one of those messengers, or the receptor it plugs into, and take it out of the conversation.

That's a genuinely different idea from the medicines you've already tried. An inhaler delivers a drug to the surface of your airways and calms whatever inflammation is there. A biologic is given as an injection and travels through your bloodstream, interrupting the signal further upstream, before your airways ever get the message.

Two things a biologic is not. It's not a stronger inhaler, and it doesn't replace one. Most people on a biologic keep taking their controller inhaler. And it isn't a steroid. That distinction matters if you've been through repeated prednisone courses and you're worried about what long-term steroid use does to bone density, blood sugar, weight, and mood. For many people, reducing steroid exposure is one of the main reasons to consider a biologic at all.

What testing establishes candidacy

Nobody should start a biologic based on a story alone. Symptoms overlap with too many other conditions, and the biologics differ enough from one another that picking the right one depends on knowing what kind of inflammation you have.

An evaluation typically looks at five things.

Spirometry: A breathing test where you blow into a tube as hard and as long as you can. It measures how much air you can move and how fast, and it can be repeated after a bronchodilator to see whether your airways open up. It gives an objective number instead of a guess.

FeNO: Short for fractional exhaled nitric oxide. You breathe out slowly into a handheld device, and it measures a gas your airways produce more of when a particular type of inflammation is active. It takes about a minute and tells us something an inhaler prescription can't.

Blood eosinophil count: Eosinophils are a white blood cell that rises in certain kinds of asthma. A standard blood draw gives the number, and it's one of the main forks in the road when choosing a drug.

Total and specific IgE: IgE is the antibody behind allergic reactions. Blood testing, sometimes alongside skin testing, shows whether allergy is driving your asthma and to what.

Documented failure of standard therapy: This is the part people underestimate. Before a biologic is appropriate, we need a real record that inhaled controller therapy at an adequate dose, taken correctly, hasn't held your asthma. That means confirming inhaler technique, confirming adherence, and ruling out the other things that masquerade as uncontrolled asthma: reflux, vocal cord dysfunction, untreated nasal disease, ongoing exposure at home or at work.

At this clinic, spirometry and FeNO are complementary when clinically indicated, so the testing that establishes candidacy isn't a separate hurdle.

The drugs and what each one targets

Xolair® (omalizumab) targets IgE, the allergy antibody. It's the option most often considered when testing shows allergic asthma driven by year-round allergens. Xolair carries an FDA boxed warning for anaphylaxis, a severe whole-body allergic reaction that can occur after a dose. That warning is the reason doses are given in a clinical setting with a period of observation afterward rather than sent home with you. It's not a formality, and it's the honest answer to "why can't I just do this myself."

Nucala® (mepolizumab) and Fasenra® (benralizumab) both act on the interleukin-5 pathway, the signal that recruits and sustains eosinophils. They're used in eosinophilic asthma, which is why the blood eosinophil count matters so much in the workup.

Tezspire® (tezepelumab) works further upstream, on TSLP, a signal your airway lining releases early in the inflammatory cascade. Because it acts before the pathway branches, it's used across asthma types rather than only in eosinophilic asthma.

Dupixent® (dupilumab) blocks signaling from IL-4 and IL-13, two messengers central to type 2 inflammation. It's a major asthma biologic, and it also carries approvals in atopic dermatitis, chronic rhinosinusitis with nasal polyps, and several other conditions. If you have asthma plus eczema plus polyps, that overlap is part of the conversation.

A note, because the names blur together. Adbry® (tralokinumab) and Ebglyss® (lebrikizumab) target IL-13 and are used in atopic dermatitis, not asthma. Nemluvio® (nemolizumab) targets IL-31, the itch signal, and its first FDA approval was for prurigo nodularis. Those three sit in a different category from the asthma drugs above, and it's worth knowing that before you read a forum post and assume they're interchangeable.

What treatment actually looks like

Injections, on a schedule, indefinitely. That's the short version, and it's better to hear it up front.

Depending on which drug you and your physician choose, doses fall somewhere between every two weeks and every eight weeks. Some are given in the clinic. Others may eventually be given at home once you've been trained and observed, though not all of them, and Xolair in particular is administered under supervision because of the anaphylaxis warning.

The injection itself is quick, into the fat under the skin of the thigh, abdomen or upper arm. Most people describe stinging for a moment and a sore spot afterward.

Response takes time. This isn't a rescue inhaler. You're generally looking at a period of months before it's clear whether the drug is doing what you hoped, and "working" is measured concretely: fewer flares, fewer steroid courses, better spirometry, more days where you don't think about your lungs. If the first biologic doesn't deliver, switching to one that targets a different pathway is a normal next step, not a failure.

The honest limits

Biologics are expensive. That's the first limit, and pretending otherwise helps nobody.

They're also not first-line. If you haven't had your inhaler technique verified, or your nasal disease is untreated, or there's a cat sleeping on your pillow, the right move is to fix those things first. A biologic layered on top of an uncorrected basic problem is an expensive way to stay uncomfortable.

Treatment is ongoing. These drugs suppress a signal while you're taking them. Stopping generally means the signal comes back, so this is a long-term commitment rather than a course you finish.

And there are real side effects. Injection site reactions are common. Headache and fatigue are reported. Some of these drugs are associated with an increased risk of certain infections, and Dupixent has a well-described association with eye irritation and conjunctivitis in some patients. Xolair's boxed warning for anaphylaxis stands apart from the rest in seriousness. Ask your physician for the full profile of the specific drug being proposed for you, not the category.

At this clinic, biologics are priced flat on a yearly basis for the administrative work to get them approved with is often a very long and arduous process. You will have full communication and updates from our clinic with the utmost attention to getting them approved and delivered as quickly as possible. Here, you are not just another number as we take this approach very seriously in order to fast-track the medication immediately. Your insurance will handle the cost of the actual drug.

How this works here

Here, one physician handles the whole arc. Dr. Stanga does the evaluation, reads the spirometry and FeNO, orders and interprets the labs, writes the prescription, oversees administration, and follows up with you afterward. Same person, same office, every visit.

Questions people ask before starting

Is a biologic a steroid?

No, a biologic is not a steroid. Steroids broadly dampen the immune system, while a biologic blocks one specific inflammatory signal and leaves the rest alone. For people who've needed repeated prednisone courses, reducing that steroid exposure is often one of the goals of starting a biologic in the first place.

Do I stop my inhaler once I start?

No, most people continue their controller inhaler while on a biologic. The biologic works upstream in your immune system, and the inhaler still does its job at the airway surface. Any change to your inhaler regimen should come from your physician after seeing how you respond, not from feeling better in the first few weeks.

How do I know which biologic is right for me?

The choice depends on what your testing shows, particularly your blood eosinophil count, your IgE and allergy results, and your FeNO. Those numbers point toward the pathway that's driving your asthma, and each drug targets a different one. That's why the workup comes before the prescription rather than after.

What if the first one doesn't help?

Switching to a biologic that targets a different pathway is a normal and expected step. Response is judged over months using concrete measures, including flare frequency, steroid courses and spirometry, not just how you feel on a given day. If the results aren't there, that information is useful and it guides the next choice.

References

1. American Academy of Allergy, Asthma & Immunology, "Biologics for the Treatment of Asthma," https://www.aaaai.org/conditions-treatments/library/asthma-library/biologics-asthma
2. American College of Allergy, Asthma & Immunology, "Severe Asthma," https://acaai.org/asthma/types-of-asthma/severe-asthma/
3. U.S. Food and Drug Administration, prescribing information and boxed warning search, https://www.accessdata.fda.gov/scripts/cder/daf/
4. American Lung Association, "Severe Asthma," https://www.lung.org/lung-health-diseases/lung-disease-lookup/asthma/asthma-symptoms-causes-risk-factors/severe-asthma
5. National Institute of Allergy and Infectious Diseases, "Asthma," https://www.niaid.nih.gov/diseases-conditions/asthma

If your asthma still runs your calendar after you've done everything asked of you, that's worth a real evaluation. Call 515-644-8448 to schedule with Dr. Stanga in West Des Moines. No referral needed, and no insurance is billed.

This article is general information, not medical advice. It cannot account for your individual history, and it is not a substitute for evaluation by a physician. If you are having trouble breathing, swelling of the lips, tongue or throat, or a reaction that is spreading, use epinephrine if you have it and call 911.